Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting

Background: Biological agents used for the treatment of psoriatic arthritis (PsA) and rheumatoid arthritis (RA) are associated with serious adverse effects (SAEs). Although several biologics have demonstrated good efficacy and tolerability in short-term trials, treatment guidelines recommend them as...

Descripción completa

Detalles Bibliográficos
Autores principales: de Camargo, Mayara Costa, Barros, Bruna Cipriano Almeida, Fulone, Izabela, Silva, Marcus Tolentino, Silveira, Miriam Sanches do Nascimento, de Camargo, Iara Alves, Barberato-Filho, Silvio, Del Fiol, Fernando de Sá, Lopes, Luciane Cruz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749844/
https://www.ncbi.nlm.nih.gov/pubmed/31572173
http://dx.doi.org/10.3389/fphar.2019.00965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749844/
https://www.ncbi.nlm.nih.gov/pubmed/31572173
http://dx.doi.org/10.3389/fphar.2019.00965

Ejemplares similares